Device Manufacturers
Growing up in Chicago, Canada was a place that my father told me provided “virgin” lakes for fishing we would visit before anyone else (supposedly). Canada also supplied the United States with hockey players and acid rain while we provided...
Will Not Using Image Analysis in Pathology be Perceived as Irrespon...
- Advocacy
- Anatomic Pathology
- Blogs
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- TeleHealth
- Web/Tech
- Whole slide
Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com. It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...
This looks interesting. Wonder if this will generate more mammograms, more abnormal mammograms and more breast biopsies with potential to detect disease at an earlier stage. Does sound like a bold prediction putting the technology at point...
Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement...
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...
One of the best parts of this job, being a news gatherer and news distributor for all of you is getting to know about several great companies and the dedicated people who make them go. One of those companies is Indica Labs based in New...































